Skip to main content

Closed

PHAT: Phathom Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

7thpctl

Volume

2.75×avg

Market Cap

697.86MUSD

P/E Ratio

-6.8TTM

Div Yield

-ann

Phathom Pharmaceuticals, Inc.

PHATNASDAQ Global Select·USD·Closed

Phathom Pharmaceuticals, Inc.

PHATNASDAQ·USD·Closed

$8.75

−3.10%

$8.75

−$0.28 (3.10%)

52W Range

7thpctl

Volume

2.75×avg

Mkt Cap

697.86MUSD

P/E

-6.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings